Abstract: The present invention is directed to compounds of formula I: wherein X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, R1, R2, R3, R4, and n are as defined for formula I in the description. The invention also relates to processes for the preparation of the compounds and to new intermediates employed in the preparation, pharmaceutical compositions containing the compounds, and to the use of the compounds in therapy.

Abstract: The invention discloses an apparatus in a wireless telecommunications system, comprising at least a first antenna of a first polarization and a second antenna of a second polarization. The apparatus additionally comprises a receiver and a transmitter, and is intended for communication with at least one other device in the wireless telecommunications system. The apparatus is equipped with means for estimating the polarization state of a signal which is received from the one other device, and the apparatus additionally comprises means for adapting the polarization state of signals transmitted from the apparatus to the one other device on the basis of said estimate of the received signal.

Abstract: An implant for percutaneous implantation through the abdominal wall for encircling and engaging an externalised length of a body duct of a human or animal patient. The implant has an exterior ring section protruding outwardly from the abdominal wall with a free end which serves for mounting of a detachable device, and an interior section extending through the abdominal wall and inside the patient for internal fixation of the implant. The exterior ring section and interior section have a common axis. The internal circumference of at least a part of the exterior ring section above the interior section is arranged with a biocompatible, integrated ingrowth means for the exterior surface of the body duct wall.

Abstract: A device for transmitting rotary motion. The device includes a motion-transmitting member for transforming an alternating rotary motion of a input drive shaft into a unidirected rotary motion of a driven body driven about a drive shaft. The motion-transmitting member includes an intermediate body rotatable about an axis of rotation. A mechanical energy accumulation member is mechanically connected to the driven body. The intermediate body includes a cam disk in the form of a driving pulley and the mechanical energy accumulation member includes a tensile/compressive spring unit.

Abstract: The present invention relates to new compounds of formula I, a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing compounds of the formula I and to the use of compounds of the formula I in therapy.

Abstract: The invention discloses a system (200) for cellular mobile telephony, comprising a base station antenna (500, 600, 700) and a plurality of cells (203, 310, 320, 330). Each cell has an area defined by an azimuth (?1, a2) and a range (R0 R?), and the first (310) and second (320) cell cover respective areas, said areas being defined by first (?1,) and second (?2) azimuths and first and second ranges (Ro) respectively. The first and second cells are essentially adjacent to each other in azimuth, and the system also comprises a third cell (203, 330) with an area coverage defined by a third azimuth and a third range (R?). The third azimuth is essentially the same as, and coinciding with, the total azimuths of the first and the second cell, but the third cell has a range coverage which is much smaller than the first or second range coverages.

Abstract: An antenna device for a radio base station in a mobile cellular telephony network. The device includes a first sub-antenna with a first feed network for distributing signals within the first sub-antenna, and a second sub-antenna with a second feed network for distributing signals within the second sub-antenna. The first and second feed networks are connected to a common main feed network, thus providing the device with a single feed port. A first controller controls one or both of the sub-antennas, and may introduce time delays in signals being transmitted or received by one or both of the sub-antennas. The device may also include a second controller for controlling the common main feed network.

Abstract: The present invention relates to new compounds of formula I, to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.

Abstract: The present invention relates to new compounds of formula I, to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.

Abstract: The present invention relates to new compounds of formula I, to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.

Abstract: The present invention relates to new compounds of formula I, to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.

Abstract: The present invention relates to a power switch, data system, interface and a data structure for controlling power outlets on one or more power switches. Each power switch comprises a sensor bus and watt meters in order to be able to monitor power consumption and environmental changes. Furthermore the power switches comprises a memory and a processor in order to be able to automatically control the power outlets without interference from a user terminal.

Abstract: The invention discloses an antenna device (500, 600, 700) for a radio base station in a cellular telephony system, which comprises a first and a second input connection for a first (D1) and a second (D2) data stream, and a first (510, 610, 710) and a second (511, 611, 711) polarization former, one for each of said data streams. The device also comprises a first (530, 630, 730) and a second (532, 632, 732) antenna of respective first and second polarizations, and one amplifier each. The device also comprises a first (515, 615, 715) and a second (516, 616, 716) combiner, so that the outputs from the polarization formers may be combined as input to each of the first and second antennas.

Abstract: The present invention relates to new compounds of formula I, wherein P, Q, X1, X2, X3, X4, R1, R2, m and p, are as defined as in formula I, or salts, solvates or solvated salts thereof, processes for their preparation and new intermediates used in the preparation thereof, pharmaceutical compositions containing said compounds, and to the use of said compounds in therapy.

Abstract: The present invention is directed to compounds of formula: (I); wherein X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, R1, R2, R3, R4, and n are as defined for formula I in the description. The invention also relates to processes for the preparation of the compounds and to new intermediates employed in the preparation, pharmaceutical compositions containing the compounds, and to the use of the compounds for treating gastrointestinal disorders.

Abstract: The present invention relates to new compounds of formula (I), wherein P, Q, X1, X2, X3, X4, X7, X8, R1, R2, R3, m, n, and p are as defined as in formula (I), or salts, or hydrates thereof, processes for their preparation and new intermediates used in the preparation thereof, pharmaceutical compositions containing said compounds and to the use of said compounds in therapy, especially for the treatment of mGluR5 receptor mediated disorders, and for the treatment of neurological disorders, psychiatric disorders, gastrointestinal disorders and pain disorders.

Abstract: The present invention relates to new compounds of formula (I), to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.

Abstract: The present invention relates to new compounds of formula I, a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.

Abstract: A method and a system for transforming between one or more point type sources and a line source in a transmission line structure. A transmission line path controller is inserted between a first parallel-plate waveguide section and a second parallel-plate waveguide section. The transmission line path controller comprises a curved side to which one end of each waveguide is coupled. The transmission line path controller further comprises a waveguide slot, one side of which is a part of the curved side, coupling the waveguide ends that are coupled to the transmission line path controller. The ends of the waveguides that are not coupled to the transmission line path controller forms the point type source and the line source, respectively.

Abstract: A percutaneous implant serves for implantation into an animal or a human body. The implant is of the kind that has an axial interior section for fixation inside the body, an axial exterior section in communication with the interior section and extending outwards from the body with a free end. The free end of the exterior section serves for mounting of a detachable device. A distal end of the interior section opposite the exterior section is provided with an anchoring section, extending radially from the distal end of the interior section. The anchoring section comprises an inner anchoring ring extending from or integral with the interior section, an outer anchoring ring, and at least one connection member for connecting the inner anchoring ring with the outer anchoring ring.